Tenpoint Therapeutics Ltd. Appoints Carol Kearney as Chief Commercial Officer

LONDON & SEATTLE--(BUSINESS WIRE)--Tenpoint Therapeutics Ltd. (“Tenpoint”), a global, clinical-stage biotechnology company focused on developing groundbreaking treatments to rejuvenate vision in the aging eye, today announced the appointment of Carol Kearney as Chief Commercial Officer (CCO). In this role, Kearney will be spearheading Tenpoint’s commercial strategy, including preparation of the potential U.S. launch of BRIMOCHOL™ PF, an investigational, preservative-free, once-daily eye drop de